Skip to search formSkip to main contentSkip to account menu

ursodeoxycholic acid N-acetylglucosaminide

Known as: Cholan-24-oic acid, 3-((2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)oxy)-7-hydroxy-, (3alpha,5beta,7beta)-, GlcNAc-UDCA, UDCA-NAGA 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AcetylglucosamineUrsodiol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease.
2016
2016
Solidification drug nanosuspensions into nanocrystals by freeze-drying: a case study with ursodeoxycholic acid
Abstract To elucidate the effect of solidification processes on the redispersibility of drug nanocrystals (NC) during freeze… 
2013
2013
Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
Ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE) is a hepatoprotectant in inhibiting apoptosis, inflammation, and… 
Highly Cited
2006
Highly Cited
2006
Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver
Ursodeoxycholic acid exerts anticholestatic effects in chronic cholestatic liver disease in humans as well as in experimental… 
1991
1991
16.胆道閉鎖症術後における UDCA 経口負荷試験の意義(第44回日本小児外科学会北海道地方会)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)